These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34252861)

  • 1. Apoptotic effect of chromanone derivative, hyrtiosone A from marine demosponge Hyrtios erectus in hepatocellular carcinoma HepG2 cells.
    Chakraborty K; Francis P
    Bioorg Chem; 2021 Sep; 114():105119. PubMed ID: 34252861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allyl-isatin suppresses cell viability, induces cell cycle arrest, and promotes cell apoptosis in hepatocellular carcinoma HepG2 cells.
    Bian W; An Y; Qu H; Yang Y; Yang J; Xu Y
    Fundam Clin Pharmacol; 2016 Jun; 30(3):253-62. PubMed ID: 26945926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Apoptosis by Nano-Synthesized Complexes of H2L and its Cu(II) Complex in Human Hepatocellular Carcinoma Cells.
    Diab T; Mohamed TM; Hamed A; Gaber M
    Anticancer Agents Med Chem; 2021; 21(9):1151-1159. PubMed ID: 32013853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tabersonine Induces the Apoptosis of Human Hepatocellular Carcinoma
    Li X; Li X; Chen L; Deng Y; Zheng Z; Ming Y
    Anticancer Agents Med Chem; 2024; 24(10):764-772. PubMed ID: 38465429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 5-aryl-3-thiophen-2-yl-1H-pyrazoles as a new class of Hsp90 inhibitors in hepatocellular carcinoma.
    Mohamady S; Ismail MI; Mogheith SM; Attia YM; Taylor SD
    Bioorg Chem; 2020 Jan; 94():103433. PubMed ID: 31785857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model.
    Abdel-Hamid NI; El-Azab MF; Moustafa YM
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):379-395. PubMed ID: 28070612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of novel hybrids targeting mTOR and HDACs for potential treatment of hepatocellular carcinoma.
    Zhai S; Zhang H; Chen R; Wu J; Ai D; Tao S; Cai Y; Zhang JQ; Wang L
    Eur J Med Chem; 2021 Dec; 225():113824. PubMed ID: 34509167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
    Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detailed studies on the anticancer action of rosmarinic acid in human Hep-G2 liver carcinoma cells: evaluating its effects on cellular apoptosis, caspase activation and suppression of cell migration and invasion.
    Jin B; Liu J; Gao D; Xu Y; He L; Zang Y; Li N; Lin D
    J BUON; 2020; 25(3):1383-1389. PubMed ID: 32862580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A newly isolated strain of Halomonas sp. (HA1) exerts anticancer potential via induction of apoptosis and G
    El-Garawani IM; El-Sabbagh SM; Abbas NH; Ahmed HS; Eissa OA; Abo-Atya DM; Khalifa SAM; El-Seedi HR
    Sci Rep; 2020 Aug; 10(1):14076. PubMed ID: 32826930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomad Jellyfish
    Tawfik MM; Eissa N; Althobaiti F; Fayad E; Abu Almaaty AH
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant and apoptotic effects of Callistemon lanceolatus leaves and their compounds against human cancer cells.
    Ahmad K; Hafeez ZB; Bhat AR; Rizvi MA; Thakur SC; Azam A; Athar F
    Biomed Pharmacother; 2018 Oct; 106():1195-1209. PubMed ID: 30119188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells.
    Kuo YC; Kuo PL; Hsu YL; Cho CY; Lin CC
    Life Sci; 2006 Apr; 78(22):2550-7. PubMed ID: 16337242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic strigolactone analogues reveal anti-cancer activities on hepatocellular carcinoma cells.
    Hasan MN; Choudhry H; Razvi SS; Moselhy SS; Kumosani TA; Zamzami MA; Omran Z; Halwani MA; Al-Babili S; Abualnaja KO; Al-Malki AL; Alhosin M; Asami T
    Bioorg Med Chem Lett; 2018 Apr; 28(6):1077-1083. PubMed ID: 29456109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Cancer Effects of Citalopram on Hepatocellular Carcinoma Cells Occur via Cytochrome C Release and the Activation of NF-kB.
    Ahmadian E; Eftekhari A; Babaei H; Nayebi AM; Eghbal MA
    Anticancer Agents Med Chem; 2017 Nov; 17(11):1570-1577. PubMed ID: 28356024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.
    Wang J; Zheng T; Chen X; Song X; Meng X; Bhatta N; Pan S; Jiang H; Liu L
    J Gastroenterol Hepatol; 2011 Feb; 26(2):371-7. PubMed ID: 21261729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking.
    Eldehna WM; Fares M; Ibrahim HS; Aly MH; Zada S; Ali MM; Abou-Seri SM; Abdel-Aziz HA; Abou El Ella DA
    Eur J Med Chem; 2015 Jul; 100():89-97. PubMed ID: 26071861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Effect of α-Solanine and Cisplatin Induces Apoptosis and Enhances Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells.
    El-Daly SM; Gouhar SA; Gamal-Eldeen AM; Abdel Hamid FF; Ashour MN; Hassan NS
    Anticancer Agents Med Chem; 2019; 19(18):2197-2210. PubMed ID: 31566136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative activity of (R)-4'-methylklavuzon on hepatocellular carcinoma cells and EpCAM
    Delman M; Avcı ST; Akçok İ; Kanbur T; Erdal E; Çağır A
    Eur J Med Chem; 2019 Oct; 180():224-237. PubMed ID: 31306909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.